
Join to View Full Profile
1441 Eastlake Ave# NTT3459Los Angeles, CA 90089
Phone+1 323-865-3105
Fax+1 612-904-4358
Dr. Ladha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Hennepin HealthcareResidency, Internal Medicine, 2009 - 2012
- Aga Khan Medical CollegeClass of 2007
Certifications & Licensure
- AZ State Medical License 2025 - 2026
- CA State Medical License 2018 - 2026
- NY State Medical License 2016 - 2019
- WI State Medical License 2013 - 2017
- MN State Medical License 2012 - 2015
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Real World Outcomes for Young Adult Patients Receiving CD19 CAR T-cell Therapy.Hannah Lust, Liora M Schultz, Soyang Kwon, Gregory W Roloff, Ibrahim Aldoss
Blood Advances. 2025-03-24 - Combination of 2-Chlorodeoxyadenosine, Cytarabine, and Granulocyte Colony-Stimulating Factor and Venetoclax in a Case of Acute Myelogenous Leukemia.Ella Prebel Jackert, Karrune Woan, Preet Chaudhary, George Yaghmour, Abdullah Ladha
Journal of Medical Cases. 2025-03-01 - 3 citationsOutcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, Chenyu Lin, Simone E Dekker
Journal of Clinical Oncology. 2025-02-10
Authored Content
- Hepatic Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients with Prior Exposure to Gemtuzumab Ozogamicin or Inotuzumab OzogamicinSeptember 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: